journal articleLitStream CollectionBusiness as usual2001 Nature Biotechnologydoi: 10.1038/nbt1001-891bpmid: 11581636
journal articleLitStream CollectionHomegrown common sense2001 Nature Biotechnologydoi: 10.1038/nbt1001-891apmid: 11581635
journal articleLitStream CollectionDeclaration of financial interestsCampbell, Philip2001 Nature Biotechnologydoi: 10.1038/nbt1001-892pmid: 11581637
journal articleLitStream CollectionUS stem cell policy comes under fireFletcher, Liz2001 Nature Biotechnologydoi: 10.1038/nbt1001-893pmid: 11581638
journal articleLitStream CollectionMore biotechs gamble on convertiblesMitchell, Pete2001 Nature Biotechnologydoi: 10.1038/nbt1001-894pmid: 11581639
journal articleLitStream CollectionIndian seed bill forges new groundJayaraman, KS2001 Nature Biotechnologydoi: 10.1038/nbt1001-895pmid: 11581640
journal articleLitStream CollectionBayer lapse exposes pharma's vulnerabilityHodgson, John2001 Nature Biotechnologydoi: 10.1038/nbt1001-897bpmid: 11581642
journal articleLitStream CollectionUS, EU prepare for further biotech food disputeFox, Jeffrey L2001 Nature Biotechnologydoi: 10.1038/nbt1001-897apmid: 11581641
journal articleLitStream CollectionAnalysts: Isis–Lilly deal validates antisenseNiiler, Eric2001 Nature Biotechnologydoi: 10.1038/nbt1001-898pmid: 11581643
journal articleLitStream CollectionIn Brief2001 Nature Biotechnologydoi: 10.1038/nbt1001-901pmid: N/A